Researchers developed a cell-based infection model for rhinovirus C (RV-C), aiming to overcome longstanding experimental constraints around studying the virus. Published in npj Viruses, the approach provides a more robust system for investigating RV-C infection biology and testing hypotheses in a controlled setting. For antiviral discovery efforts, better in vitro models can translate into faster target validation and more reliable preclinical assessments.